Melissa Adkins-Hempel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Melissa Adkins-Hempel has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Sandra J. Japuntich
Hennepin Healthcare Research Institute, Minneapolis, USA
5 shared publications - Andrew M. Busch
Behavioral Health Equity Research Group, Hennepin Healthcare Research Institute, Minneapolis, USA
3 shared publications - Sarah Ashley Helseth
Center for Dissemination and Implementation Science, Northwestern University Feinberg School of Medicine, Chicago, USA
3 shared publications - Shira Dunsiger
Brown University, Providence, USA
3 shared publications - Anne Eden Evins
Psychiatry, Massachusetts General Hospital, Boston, USA
2 shared publications - Carina Lundtvedt
Hennepin Healthcare Research Institute, Minneapolis, USA
2 shared publications
Latest Publications
Nicotine replacement therapy sampling for cigarette cessation in dental care: A National Dental Practice‐Based Research Network cluster randomized clinical trial
Background and aims: Cigarette smoking is detrimental to oral health. Oral health professionals rarely prescribe smoking cessation medications. Nicotine replacement therapy sampling (NRTS), providing brief starter courses of NRT, could improve provision of NRT and promote cessation. The aim of the Free Samples for Health (FreSH) study was to test the effectiveness of NRTS compared with enhanced usual care on long‐term abstinence from combustible tobacco. Design: Two‐group, pragmatic, cluster (dental practice) randomized clinical trial. Setting: The study was conducted in the Midwest and Northeast nodes of the United States' National Dental Practice‐Based Research Network in 59 dental practices. Practices were randomized to intervention condition. Participants: Participants (recruited June 2023–June 2025) were adult patients of network practices who smoke cigarettes daily [ n = 1196; NRTS n = 486, comparison group (ET) n = 710; 59% female; 71% White]. Intervention and comparator: All participants received Ask‐Advise‐Refer: oral health practitioners asked smoking status, advised quitting and referred to state tobacco quitlines. Participants in the NRTS group were given a 2‐week supply of 14 mg nicotine patches and 4 mg nicotine lozenges; participants in the ET group were given an electric toothbrush. Measurements: Participants were surveyed after their visit and at 1, 3 and 6 months post enrollment. The primary outcome was 7‐day point‐prevalence abstinence measured 6 months post enrollment confirmed via expired breath carbon monoxide (CO) < 6 p.p.m. Secondary outcomes included quit attempts, short‐term abstinence, NRT and quitline use. Covariates included stage of change, confidence, readiness and cigarettes per day. Results: While there was no condition effect on CO‐confirmed abstinence at 6 months post intervention [NRTS: 8.4%, ET: 8.0%; adjusted odds ratio (aOR) = 1.04, 95% confidence interval (CI) = 0.65–2.09], the NRTS intervention statistically significantly increased NRT use across all timepoints (NRTS: 50%, ET: 13%; aOR = 7.39, 95% CI = 5.29–10.31) and quit attempts at all timepoints (NRTS: 58%, ET: 49%; aOR = 1.46, 95% CI = 1.06–2.02). There was a statistically significant effect of NRTS on self‐reported 7‐day point‐prevalence abstinence at 1 month post enrollment (NRTS: 12.8%, ET: 9.0%; aOR = 1.72, 95% CI = 1.03–2.88). There was no difference in quitline use. Practices assigned to the NRTS condition recruited notably fewer participants ( t = 2.11, P = 0.04). Summary: Free nicotine replacement therapy (NRT) samples are not sufficient to improve long‐term smoking abstinence in dental patients; however, NRT samples increase engagement with quitting behaviors and may serve as a starting point toward quitting. Low recruitment in the NRT sampling group demonstrates discomfort by oral health practitioners in discussing smoking among those not voicing readiness to quit.
Nicotine replacement therapy sampling for cigarette cessation in dental care: A National Dental Practice‐Based Research Network cluster randomized clinical trial
Background and aims: Cigarette smoking is detrimental to oral health. Oral health professionals rarely prescribe smoking cessation medications. Nicotine replacement therapy sampling (NRTS), providing brief starter courses of NRT, could improve provision of NRT and promote cessation. The aim of the Free Samples for Health (FreSH) study was to test the effectiveness of NRTS compared with enhanced usual care on long‐term abstinence from combustible tobacco. Design: Two‐group, pragmatic, cluster (dental practice) randomized clinical trial. Setting: The study was conducted in the Midwest and Northeast nodes of the United States' National Dental Practice‐Based Research Network in 59 dental practices. Practices were randomized to intervention condition. Participants: Participants (recruited June 2023–June 2025) were adult patients of network practices who smoke cigarettes daily [ n = 1196; NRTS n = 486, comparison group (ET) n = 710; 59% female; 71% White]. Intervention and comparator: All participants received Ask‐Advise‐Refer: oral health practitioners asked smoking status, advised quitting and referred to state tobacco quitlines. Participants in the NRTS group were given a 2‐week supply of 14 mg nicotine patches and 4 mg nicotine lozenges; participants in the ET group were given an electric toothbrush. Measurements: Participants were surveyed after their visit and at 1, 3 and 6 months post enrollment. The primary outcome was 7‐day point‐prevalence abstinence measured 6 months post enrollment confirmed via expired breath carbon monoxide (CO) < 6 p.p.m. Secondary outcomes included quit attempts, short‐term abstinence, NRT and quitline use. Covariates included stage of change, confidence, readiness and cigarettes per day. Results: While there was no condition effect on CO‐confirmed abstinence at 6 months post intervention [NRTS: 8.4%, ET: 8.0%; adjusted odds ratio (aOR) = 1.04, 95% confidence interval (CI) = 0.65–2.09], the NRTS intervention statistically significantly increased NRT use across all timepoints (NRTS: 50%, ET: 13%; aOR = 7.39, 95% CI = 5.29–10.31) and quit attempts at all timepoints (NRTS: 58%, ET: 49%; aOR = 1.46, 95% CI = 1.06–2.02). There was a statistically significant effect of NRTS on self‐reported 7‐day point‐prevalence abstinence at 1 month post enrollment (NRTS: 12.8%, ET: 9.0%; aOR = 1.72, 95% CI = 1.03–2.88). There was no difference in quitline use. Practices assigned to the NRTS condition recruited notably fewer participants ( t = 2.11, P = 0.04). Summary: Free nicotine replacement therapy (NRT) samples are not sufficient to improve long‐term smoking abstinence in dental patients; however, NRT samples increase engagement with quitting behaviors and may serve as a starting point toward quitting. Low recruitment in the NRT sampling group demonstrates discomfort by oral health practitioners in discussing smoking among those not voicing readiness to quit.
- Open Access
- 21 September 2026
- Published by Springer Nature in Community Mental Health Journal
- p. 1-12
Implementing Proactive Smoking Cessation Induction Interventions in a Certified Community Behavioral Health Clinic: A Pilot Type 2 Hybrid Effectiveness-Implementation Study
Background: People with mental health and substance use disorders have a high prevalence of tobacco use. Community mental health clinics, including certified behavioral health clinics, are a key entry point where people with mental health and substance use disorders receive care. Implementation strategies to deliver tobacco use disorder treatment in community health clinics are needed. Two promising strategies supported by clinical practice guidelines are proactive outreach (reaching out to people in a health system who smoke and providing treatment) and the 5As (mental health providers ask about tobacco use, advise to quit, assess interest in quitting, assist with cessation, and arrange for follow up). Methods: The current study is a pilot type two hybrid effectiveness-implementation trial conducted in a certified behavioral health clinic. The clinic received a multilevel implementation strategy comprising didactic training, performance feedback and organizational coaching to promote delivery of the 5As at intake and treatment planning visits. Clients of the organization who consented to the study also received three proactive outreach contacts over nine months offering connections to cessation counseling and medication. Clients completed study surveys at pre-implementation, implementation launch, and at 3-, 6- and 12-months post implementation launch. Providers completed surveys before and after training and at 3-, 6-, 9-, and 12-months post-training. Primary outcomes were feasibility and acceptability of the client intervention and organization implementation strategies. Secondary outcomes were preliminary indicators of patient effectiveness. Results: Client recruitment, intervention delivery, and study assessment were feasible, with 49 client participants recruited over 3 months. Outreach completion rates were higher for earlier calls and ranged from 67-94%. Retention was high with 84% of client participants completing the primary outcome assessment. The implementation strategy was also successful, with greater than 50% attendance at study trainings (77 of 125 providers attended), and feasible delivery of organizational coaching (coaching delivered to all 3 clinic sites) and performance feedback (all 3 clinic sites receiving monthly performance feedback). Acceptability ratings were high for both the intervention and the implementation strategy. Staff survey completion waned over time (completion rates 51-72%) and turnover was high. Client CO-confirmed abstinence rate at 12 months post enrollment was 8%. Conclusions: Implementing proactive tobacco use disorder treatment in a certified community behavioral health clinic was feasible and acceptable. A full scale trial to test the effectiveness of the study interventions and implementation strategy is warranted.
- 21 September 2026
- Published by Springer Nature in Community Mental Health Journal
- p. 1-12
Open AccessImplementing Proactive Smoking Cessation Induction Interventions in a Certified Community Behavioral Health Clinic: A Pilot Type 2 Hybrid Effectiveness-Implementation Study
Background: People with mental health and substance use disorders have a high prevalence of tobacco use. Community mental health clinics, including certified behavioral health clinics, are a key entry point where people with mental health and substance use disorders receive care. Implementation strategies to deliver tobacco use disorder treatment in community health clinics are needed. Two promising strategies supported by clinical practice guidelines are proactive outreach (reaching out to people in a health system who smoke and providing treatment) and the 5As (mental health providers ask about tobacco use, advise to quit, assess interest in quitting, assist with cessation, and arrange for follow up). Methods: The current study is a pilot type two hybrid effectiveness-implementation trial conducted in a certified behavioral health clinic. The clinic received a multilevel implementation strategy comprising didactic training, performance feedback and organizational coaching to promote delivery of the 5As at intake and treatment planning visits. Clients of the organization who consented to the study also received three proactive outreach contacts over nine months offering connections to cessation counseling and medication. Clients completed study surveys at pre-implementation, implementation launch, and at 3-, 6- and 12-months post implementation launch. Providers completed surveys before and after training and at 3-, 6-, 9-, and 12-months post-training. Primary outcomes were feasibility and acceptability of the client intervention and organization implementation strategies. Secondary outcomes were preliminary indicators of patient effectiveness. Results: Client recruitment, intervention delivery, and study assessment were feasible, with 49 client participants recruited over 3 months. Outreach completion rates were higher for earlier calls and ranged from 67-94%. Retention was high with 84% of client participants completing the primary outcome assessment. The implementation strategy was also successful, with greater than 50% attendance at study trainings (77 of 125 providers attended), and feasible delivery of organizational coaching (coaching delivered to all 3 clinic sites) and performance feedback (all 3 clinic sites receiving monthly performance feedback). Acceptability ratings were high for both the intervention and the implementation strategy. Staff survey completion waned over time (completion rates 51-72%) and turnover was high. Client CO-confirmed abstinence rate at 12 months post enrollment was 8%. Conclusions: Implementing proactive tobacco use disorder treatment in a certified community behavioral health clinic was feasible and acceptable. A full scale trial to test the effectiveness of the study interventions and implementation strategy is warranted.
- Open Access
- 17 April 2026
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- p. 1-15
Racial Disparities in Biopsychosocial Predictors of Short-Term Smoking Cessation Following Acute Coronary Syndrome Hospitalization
Background: Smoking cessation after an acute coronary syndrome (ACS) event is critical for reducing cardiovascular risk and mortality. However, most patients continue smoking post-hospitalization. Prior research with limited racial and sex diversity has overlooked how biopsychosocial factors may influence cessation outcomes in this high-risk group. Purpose: The current study aimed to identify biopsychosocial predictors of 7-day smoking abstinence post-discharge in a diverse cohort of hospitalized ACS patients. Methods: Pre-randomization data from the Post-Acute Cardiac Event Smoking (PACES) trial, a randomized controlled trial of integrated smoking cessation and mood management treatment, were analyzed ( N = 203, 69% male, 41% BIPOC [Black, Indigenous, and People of Color]). Univariate models identified potential predictors, which were subsequently evaluated in multivariable logistic regression models. Stratified analyses were conducted due to significant differences in abstinence rates between White and BIPOC participants. Results: Among White participants, predictors of abstinence included being male, older, in a committed relationship, having higher confidence in quitting, fewer depressive symptoms, better health-related quality of life, and no prior ACS. These factors explained 58% of the variance in abstinence. Among BIPOC participants, the only predictors of abstinence were higher cigarettes smoked per day and lower motivation to quit, collectively explaining 21% of the variance, significantly less than for White participants ( p = .01). Conclusions: Predictors of cessation for White participants aligned with prior literature, while those for BIPOC participants were inconsistent with the prior literature and explained less variance. Future research should identify meaningful predictors of abstinence in BIPOC post-ACS patients to guide culturally relevant, equity-focused cessation interventions. Clinical Trials Registration #: NCT03413423
- 17 April 2026
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- p. 1-15
Open AccessRacial Disparities in Biopsychosocial Predictors of Short-Term Smoking Cessation Following Acute Coronary Syndrome Hospitalization
Background: Smoking cessation after an acute coronary syndrome (ACS) event is critical for reducing cardiovascular risk and mortality. However, most patients continue smoking post-hospitalization. Prior research with limited racial and sex diversity has overlooked how biopsychosocial factors may influence cessation outcomes in this high-risk group. Purpose: The current study aimed to identify biopsychosocial predictors of 7-day smoking abstinence post-discharge in a diverse cohort of hospitalized ACS patients. Methods: Pre-randomization data from the Post-Acute Cardiac Event Smoking (PACES) trial, a randomized controlled trial of integrated smoking cessation and mood management treatment, were analyzed ( N = 203, 69% male, 41% BIPOC [Black, Indigenous, and People of Color]). Univariate models identified potential predictors, which were subsequently evaluated in multivariable logistic regression models. Stratified analyses were conducted due to significant differences in abstinence rates between White and BIPOC participants. Results: Among White participants, predictors of abstinence included being male, older, in a committed relationship, having higher confidence in quitting, fewer depressive symptoms, better health-related quality of life, and no prior ACS. These factors explained 58% of the variance in abstinence. Among BIPOC participants, the only predictors of abstinence were higher cigarettes smoked per day and lower motivation to quit, collectively explaining 21% of the variance, significantly less than for White participants ( p = .01). Conclusions: Predictors of cessation for White participants aligned with prior literature, while those for BIPOC participants were inconsistent with the prior literature and explained less variance. Future research should identify meaningful predictors of abstinence in BIPOC post-ACS patients to guide culturally relevant, equity-focused cessation interventions. Clinical Trials Registration #: NCT03413423
- 7 January 2026
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 16 (1)
Patient preferences for the integration of exercise for depression into mental health care
Background: Exercise is an evidence-based treatment for depression, yet it is rarely integrated into mental health care in the United States. Purpose: The purpose of this study was to examine patient experiences with and preferences for integrating exercise into mental health care. Methods: Participants were 457 US adults with depression who reported current or past receipt of mental health care and completed an online survey assessing experienced and preferred levels of exercise integration using parallel three-level ordinal scales. Related samples Wilcoxon signed-rank tests compared experienced versus preferred levels of exercise integration. Multivariable ordinal logistic regression examined predictors of preferred exercise integration. Results: 22.5% preferred no discussion of exercise in the context of mental health care, 56.5% preferred general education and encouragement around exercise in mental health care, and 21.0% preferred structured exercise goal setting in mental health care. Participants preferred significantly greater exercise integration than they had experienced (Z = 6.8, P < .001). In multivariable analyses, prior experience with exercise being integrated into mental health care and greater belief in exercise’s antidepressant effects were associated with higher preferred integration, whereas current antidepressant use and physical health conditions limiting exercise were associated with lower preferred integration. Preference for integration of exercise into mental health care was unrelated to depression severity or physical activity level. Conclusion: US adults with depression prefer greater integration of exercise into mental health care than they currently receive, but most prefer limited integration. These findings highlight the importance of flexible, patient-centered approaches to exercise integration into mental health care.
- 7 January 2026
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 16 (1)
Patient preferences for the integration of exercise for depression into mental health care
Background: Exercise is an evidence-based treatment for depression, yet it is rarely integrated into mental health care in the United States. Purpose: The purpose of this study was to examine patient experiences with and preferences for integrating exercise into mental health care. Methods: Participants were 457 US adults with depression who reported current or past receipt of mental health care and completed an online survey assessing experienced and preferred levels of exercise integration using parallel three-level ordinal scales. Related samples Wilcoxon signed-rank tests compared experienced versus preferred levels of exercise integration. Multivariable ordinal logistic regression examined predictors of preferred exercise integration. Results: 22.5% preferred no discussion of exercise in the context of mental health care, 56.5% preferred general education and encouragement around exercise in mental health care, and 21.0% preferred structured exercise goal setting in mental health care. Participants preferred significantly greater exercise integration than they had experienced (Z = 6.8, P < .001). In multivariable analyses, prior experience with exercise being integrated into mental health care and greater belief in exercise’s antidepressant effects were associated with higher preferred integration, whereas current antidepressant use and physical health conditions limiting exercise were associated with lower preferred integration. Preference for integration of exercise into mental health care was unrelated to depression severity or physical activity level. Conclusion: US adults with depression prefer greater integration of exercise into mental health care than they currently receive, but most prefer limited integration. These findings highlight the importance of flexible, patient-centered approaches to exercise integration into mental health care.
- Open Access
- 6 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0315506
Expanding first-line options for depression: Protocol of a pragmatic comparative effectiveness trial of yoga vs. behavioral activation (the COMPARE study)
Depression is a prevalent mental health condition in the United States and a significant cause of morbidity and mortality. The treatment guidelines for depression recommends either psychotherapy, such as behavioral activation (BA), or a second-generation antidepressant as a first-line treatment for adult patients with depression. However, many individuals with depression do not experience improvement from first-line treatments or choose not to engage in them due to stigma, cost, difficulty with access, and/or side effects. As such we need new treatments for depression and yoga is especially promising given recent data on its efficacy for depression. This study seeks to compare a first-line treatment for depression, or BA, versus yoga to examine whether yoga does as well as BA at improving depressive symptoms and secondary outcomes. We will also examine improvements in depressive symptoms, and secondary outcomes, by specific sub-populations to determine who might do better in which treatment (i.e., BA or yoga). Given that this is the first non-inferior, comparative effectiveness study of yoga, this paper explains the study design, the rationale for the study design, as well as lessons learned in conducting the study.
- 6 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0315506
Open AccessExpanding first-line options for depression: Protocol of a pragmatic comparative effectiveness trial of yoga vs. behavioral activation (the COMPARE study)
Depression is a prevalent mental health condition in the United States and a significant cause of morbidity and mortality. The treatment guidelines for depression recommends either psychotherapy, such as behavioral activation (BA), or a second-generation antidepressant as a first-line treatment for adult patients with depression. However, many individuals with depression do not experience improvement from first-line treatments or choose not to engage in them due to stigma, cost, difficulty with access, and/or side effects. As such we need new treatments for depression and yoga is especially promising given recent data on its efficacy for depression. This study seeks to compare a first-line treatment for depression, or BA, versus yoga to examine whether yoga does as well as BA at improving depressive symptoms and secondary outcomes. We will also examine improvements in depressive symptoms, and secondary outcomes, by specific sub-populations to determine who might do better in which treatment (i.e., BA or yoga). Given that this is the first non-inferior, comparative effectiveness study of yoga, this paper explains the study design, the rationale for the study design, as well as lessons learned in conducting the study.
- Open Access
- 16 December 2022
- Published by Cambridge University Press (CUP) in Journal of Smoking Cessation
- Vol. 2022, 1925071
Knowledge, Attitudes, and Beliefs about Relapse Prevention Research Involving Bupropion among Current and Former Pregnant Individuals Who Smoke
Introduction. While many individuals quit smoking during pregnancy, most relapse within one year postpartum. Research into methods to decrease smoking relapse postpartum has been hampered by difficulties with recruitment. Method. We conducted individual interviews with pregnant women (N = 22) who were interested in quitting smoking while pregnant about their attitudes regarding smoking and quitting during pregnancy, clinical trial participation, and smoking cessation medication use. Results. Participants were aware of the risks of smoking while pregnant. Many wanted to quit smoking before delivery. Few used empirically supported treatments to quit. While research was viewed positively, interest in taking on new commitments postpartum and taking a medication to prevent relapse was low. Medication concerns were evident among most participants, especially among those planning to breastfeed. Further, several women noted medication was unnecessary, as they did not believe they would relapse postpartum. Financial incentives, childcare, and fewer and/or remote visits were identified as facilitators to participating in research. However, these factors did not outweigh women’s concerns about medication use and time commitments. Conclusions. Women are aware that quitting smoking during pregnancy and remaining smoke-free postpartum are important. However, beliefs that personal relapse risk is low and that medications are dangerous reduced enthusiasm for taking medication for postpartum relapse prevention. Future medication trials should educate women about the high likelihood of relapse, prepare to answer detailed questions about risks of cessation medications, and connect with participants’ clinicians. For new mothers, studies conducted remotely with few scheduled appointments would reduce barriers to participation.
- 16 December 2022
- Published by Cambridge University Press (CUP) in Journal of Smoking Cessation
- Vol. 2022, 1925071
Open AccessKnowledge, Attitudes, and Beliefs about Relapse Prevention Research Involving Bupropion among Current and Former Pregnant Individuals Who Smoke
Introduction. While many individuals quit smoking during pregnancy, most relapse within one year postpartum. Research into methods to decrease smoking relapse postpartum has been hampered by difficulties with recruitment. Method. We conducted individual interviews with pregnant women (N = 22) who were interested in quitting smoking while pregnant about their attitudes regarding smoking and quitting during pregnancy, clinical trial participation, and smoking cessation medication use. Results. Participants were aware of the risks of smoking while pregnant. Many wanted to quit smoking before delivery. Few used empirically supported treatments to quit. While research was viewed positively, interest in taking on new commitments postpartum and taking a medication to prevent relapse was low. Medication concerns were evident among most participants, especially among those planning to breastfeed. Further, several women noted medication was unnecessary, as they did not believe they would relapse postpartum. Financial incentives, childcare, and fewer and/or remote visits were identified as facilitators to participating in research. However, these factors did not outweigh women’s concerns about medication use and time commitments. Conclusions. Women are aware that quitting smoking during pregnancy and remaining smoke-free postpartum are important. However, beliefs that personal relapse risk is low and that medications are dangerous reduced enthusiasm for taking medication for postpartum relapse prevention. Future medication trials should educate women about the high likelihood of relapse, prepare to answer detailed questions about risks of cessation medications, and connect with participants’ clinicians. For new mothers, studies conducted remotely with few scheduled appointments would reduce barriers to participation.
- Open Access
- 3 February 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (2) , e0261490
The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent acute coronary syndrome
Background: Patients with acute coronary syndrome (ACS) with depressed mood demonstrate poor cardiovascular behavioral risk profiles and elevated risk for recurrent ACS and mortality. Behavioral Activation (BA) offers an intervention framework for an integrated treatment targeting both depression and critical health behaviors post-ACS. Behavioral Activation for Health and Depression (BA-HD) was developed and pilot tested in a multiphase iterative process. Methods: First, an initial treatment manual was conceptualized based on the team’s prior work, as well as the extant literature. Second, qualitative interviews were conducted with target patients and target providers on the proposed BA-HD treatment rationale, content, and structure. Framework matrix analyses were used to summarize and aggregate responses. Third, an expert panel was convened to elicit additional manual refinements. Finally, patients with post-ACS depression and health behavior non-adherence were recruited to complete an open pilot trial to evaluate acceptability (Client Satisfaction Questionnaire [CSQ], exit interview) and treatment engagement (number of sessions attended; treatment completion was considered completion of 8 out of 10 possible sessions). Results: The initial BA-HD treatment manual expanded an existing treatment manual for post-ACS BA-based mood management and smoking cessation to target four health behaviors relevant to post-ACS patients (e.g., smoking cessation, medication adherence, physical activity, and diet). After the initial conceptualization, ten post-ACS patients and eight cardiac rehabilitation professionals completed qualitative interviews. Patients endorsed bi-directional interactions between mood and health behaviors post-ACS. Both patients and providers expressed general support of the proposed treatment rationale and values-guided, collaborative goal-setting approach. Patients, providers, and experts provided feedback that shaped the iterative manual development. After the BA-HD manual was finalized, eight participants were enrolled in a single-arm pilot trial. The mean CSQ score was 30.57 ± 2.23, indicating high satisfaction. Seven out of eight (88%) completed treatment. Pre- to post treatment improvements in depressed mood and health behaviors were promising. Conclusions: BA-HD treatment is an acceptable approach to target both mood and health behaviors in post-ACS patients with depression. A future larger, controlled trial is needed to evaluate the efficacy of the BA-HD treatment. Trial registration: ClinicalTrials.gov Identifier: NCT04158219
- 3 February 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (2) , e0261490
Open AccessThe development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent acute coronary syndrome
Background: Patients with acute coronary syndrome (ACS) with depressed mood demonstrate poor cardiovascular behavioral risk profiles and elevated risk for recurrent ACS and mortality. Behavioral Activation (BA) offers an intervention framework for an integrated treatment targeting both depression and critical health behaviors post-ACS. Behavioral Activation for Health and Depression (BA-HD) was developed and pilot tested in a multiphase iterative process. Methods: First, an initial treatment manual was conceptualized based on the team’s prior work, as well as the extant literature. Second, qualitative interviews were conducted with target patients and target providers on the proposed BA-HD treatment rationale, content, and structure. Framework matrix analyses were used to summarize and aggregate responses. Third, an expert panel was convened to elicit additional manual refinements. Finally, patients with post-ACS depression and health behavior non-adherence were recruited to complete an open pilot trial to evaluate acceptability (Client Satisfaction Questionnaire [CSQ], exit interview) and treatment engagement (number of sessions attended; treatment completion was considered completion of 8 out of 10 possible sessions). Results: The initial BA-HD treatment manual expanded an existing treatment manual for post-ACS BA-based mood management and smoking cessation to target four health behaviors relevant to post-ACS patients (e.g., smoking cessation, medication adherence, physical activity, and diet). After the initial conceptualization, ten post-ACS patients and eight cardiac rehabilitation professionals completed qualitative interviews. Patients endorsed bi-directional interactions between mood and health behaviors post-ACS. Both patients and providers expressed general support of the proposed treatment rationale and values-guided, collaborative goal-setting approach. Patients, providers, and experts provided feedback that shaped the iterative manual development. After the BA-HD manual was finalized, eight participants were enrolled in a single-arm pilot trial. The mean CSQ score was 30.57 ± 2.23, indicating high satisfaction. Seven out of eight (88%) completed treatment. Pre- to post treatment improvements in depressed mood and health behaviors were promising. Conclusions: BA-HD treatment is an acceptable approach to target both mood and health behaviors in post-ACS patients with depression. A future larger, controlled trial is needed to evaluate the efficacy of the BA-HD treatment. Trial registration: ClinicalTrials.gov Identifier: NCT04158219
- Open Access
- 25 August 2020
- Published by Center for Open Science in PsyArXiv
Second-guessing of Spinoza: Psychophysiological and behavioral evidence that believing is default during proposition comprehension
The belief-default model contends that believing is inexorable during comprehension, and falsification is a subsequent, secondary process. By contrast, the Cartesian belief-fixation model argues that naïve propositions may be mentally represented without a truth or falsity stance. In the present research, data from four studies help adjudicate belief-fixation models, favoring the belief-default model: Studies 1-3 show that newly represented propositions are initially believed as the consequences of the truth from a naïve represented proposition will automatically activate contradictory mental information even when this processing impairs task performance (a “false” false alarm belief bias). Naïve propositions cannot be “merely” represented (without a truth stance) during comprehension. Studies 3 and 4 reveal unique electrodermal activity signals corresponding to propositions considered to be either true or false. We argue that the observed autonomic reactivity constitutes the source of two different epistemic emotions associated with the perceived outcomes of a memory search (i.e., “aha” and wrongness, respectively). To account for the psychophysiological results, we hypothesize that the epistemic emotion of familiarity is substantiated by an “aha” emotion which signals the recovery of represented propositions considered true during mnemonic processing. In addition, we show that anti-belief-default conclusions from recent investigations using multinomial processing tree modeling are tenuous as they depend on the type of false information paradigm employed. In sum, the data support the belief-default model and indicate a novel psychophysiological method to distinguish “believed” memory retrieval products from “guessed” responses derived via metacognitive strategies during veridical identification.
- 25 August 2020
- Published by Center for Open Science in PsyArXiv
Open AccessSecond-guessing of Spinoza: Psychophysiological and behavioral evidence that believing is default during proposition comprehension
The belief-default model contends that believing is inexorable during comprehension, and falsification is a subsequent, secondary process. By contrast, the Cartesian belief-fixation model argues that naïve propositions may be mentally represented without a truth or falsity stance. In the present research, data from four studies help adjudicate belief-fixation models, favoring the belief-default model: Studies 1-3 show that newly represented propositions are initially believed as the consequences of the truth from a naïve represented proposition will automatically activate contradictory mental information even when this processing impairs task performance (a “false” false alarm belief bias). Naïve propositions cannot be “merely” represented (without a truth stance) during comprehension. Studies 3 and 4 reveal unique electrodermal activity signals corresponding to propositions considered to be either true or false. We argue that the observed autonomic reactivity constitutes the source of two different epistemic emotions associated with the perceived outcomes of a memory search (i.e., “aha” and wrongness, respectively). To account for the psychophysiological results, we hypothesize that the epistemic emotion of familiarity is substantiated by an “aha” emotion which signals the recovery of represented propositions considered true during mnemonic processing. In addition, we show that anti-belief-default conclusions from recent investigations using multinomial processing tree modeling are tenuous as they depend on the type of false information paradigm employed. In sum, the data support the belief-default model and indicate a novel psychophysiological method to distinguish “believed” memory retrieval products from “guessed” responses derived via metacognitive strategies during veridical identification.
- Open Access
- 29 May 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (10) , 2983-2989
Experiences with Work and Participation in Public Programs by Low-Income Medicaid Enrollees Using Qualitative Interviews
Background Centers for Medicare & Medicaid Services (CMS) began encouraging governors to implement work requirements for Medicaid enrollees using section 1115 waivers in 2018. Significant controversy surrounds such attempts, but we know little about the perceptions and experiences of enrollees. Objective To characterize experiences of work and its relationship to participation in Medicaid and other public programs among potential targets of Medicaid work requirements. Design In-depth, semi-structured, one-time qualitative interviews. Participants 35 very low-income, non-disabled Medicaid expansion enrollees participating in a county-sponsored Medicaid managed care plan as a part of a larger study. Approach We used a biographical narrative interpretive method during interviews including questions about the use of employment and income support and other public programs including from state and federal disability programs. Our team iteratively coded verbatim transcripts allowing for emergent themes. Key Results Interview data revealed high motivation for, and broad participation in, formal and informal paid work. Eight themes emerged: (1) critical poverty (for example, “I’m not content, but what choices do I have?”); (2) behavioral and physical health barriers to work; (3) social barriers: unstable housing, low education, criminal justice involvement; (4) work, pride, and shame; (5) inflexible, unstable work (for example, “Can I have a job that will accommodate my doctor appointments?…Will my therapy have to suffer? You know? So it’s a double edged sword.”); (6) Medicaid supports the ability to work; (7) lack of transparency and misalignment of program eligibility (for example, “It’s not like I don’t want to work because I would like to work. It’s just that I don’t want to be homeless again, right?”); and (8) barriers, confusion, and contradictions about federal disability. Conclusions We conclude that bipartisan solutions prioritizing the availability of well-paying jobs and planful transitions off of public programs would best serve very low-income, work-capable Medicaid enrollees.
- 29 May 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (10) , 2983-2989
Open AccessExperiences with Work and Participation in Public Programs by Low-Income Medicaid Enrollees Using Qualitative Interviews
Background Centers for Medicare & Medicaid Services (CMS) began encouraging governors to implement work requirements for Medicaid enrollees using section 1115 waivers in 2018. Significant controversy surrounds such attempts, but we know little about the perceptions and experiences of enrollees. Objective To characterize experiences of work and its relationship to participation in Medicaid and other public programs among potential targets of Medicaid work requirements. Design In-depth, semi-structured, one-time qualitative interviews. Participants 35 very low-income, non-disabled Medicaid expansion enrollees participating in a county-sponsored Medicaid managed care plan as a part of a larger study. Approach We used a biographical narrative interpretive method during interviews including questions about the use of employment and income support and other public programs including from state and federal disability programs. Our team iteratively coded verbatim transcripts allowing for emergent themes. Key Results Interview data revealed high motivation for, and broad participation in, formal and informal paid work. Eight themes emerged: (1) critical poverty (for example, “I’m not content, but what choices do I have?”); (2) behavioral and physical health barriers to work; (3) social barriers: unstable housing, low education, criminal justice involvement; (4) work, pride, and shame; (5) inflexible, unstable work (for example, “Can I have a job that will accommodate my doctor appointments?…Will my therapy have to suffer? You know? So it’s a double edged sword.”); (6) Medicaid supports the ability to work; (7) lack of transparency and misalignment of program eligibility (for example, “It’s not like I don’t want to work because I would like to work. It’s just that I don’t want to be homeless again, right?”); and (8) barriers, confusion, and contradictions about federal disability. Conclusions We conclude that bipartisan solutions prioritizing the availability of well-paying jobs and planful transitions off of public programs would best serve very low-income, work-capable Medicaid enrollees.